AXIM Biotechnologies, Inc. (AXIM)
OTCMKTS: AXIM · Delayed Price · USD
+0.0020 (20.00%)
May 20, 2024, 1:59 PM EDT - Market closed

AXIM Biotechnologies Market Cap

AXIM Biotechnologies has a market cap or net worth of $3.34 million as of May 20, 2024. Its market cap has decreased by -35.52% in one year.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since May 21, 2019, AXIM Biotechnologies's market cap has decreased from $71.47M to $3.34M, a decrease of -95.33%. That is a compound annual growth rate of -45.84%.


DateMarket Cap% Change
May 17, 20243.05M27.00%
May 16, 20242.40M5.26%
May 15, 20242.28M9.20%
May 14, 20242.09M-13.00%
May 13, 20242.40M-4.49%
May 10, 20242.51M-11.27%
May 9, 20242.83M16.83%
May 8, 20242.43M-
May 7, 20242.43M-8.01%
May 6, 20242.64M-4.10%
May 3, 20242.75M-6.15%
May 2, 20242.93M-18.67%
May 1, 20243.60M1.35%
Apr 30, 20243.55M7.25%
Apr 29, 20243.31M0.73%
Apr 26, 20243.29M11.84%
Apr 25, 20242.94M18.93%
Apr 24, 20242.47M-5.50%
Apr 23, 20242.62M-14.17%
Apr 22, 20243.05M-15.33%
Apr 19, 20243.60M-3.23%
Apr 18, 20243.72M-
Apr 17, 20243.72M11.67%
Apr 16, 20243.33M-11.03%
Apr 15, 20243.75M6.85%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 731.81B
Novo Nordisk 582.01B
UnitedHealth Group 482.86B
Johnson & Johnson 372.17B
Merck & Co. 332.08B
AbbVie 293.88B
AstraZeneca 238.44B
Thermo Fisher 227.24B
Market Cap Rankings